01 1Srini Pharmaceuticals
01 1OMEPRAZOLE USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2013-02-27
Pay. Date : 2013-02-11
DMF Number : 22471
Submission : 2009-01-30
Status : Active
Type : II
20
Srini Pharmaceuticals Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is OMEPRAZOLE USP, with a corresponding US DMF Number 22471.
Remarkably, this DMF maintains an Active status since its submission on January 30, 2009, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 27, 2013, and payment made on February 11, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
